Announcements

HPTN Awarded U.S. National Institutes of Health Funding to Continue Research Agenda

HPTN Awarded U.S. National Institutes of Health Funding to Continue Research Agenda

Nov 30, 2020

The Women of HPTN 084

HPTN 084 Study Demonstrates Superiority of Injectable Cabotegravir to Oral FTC/TDF for the Prevention of HIV in Cisgender Women in Sub-Saharan Africa

Nov 9, 2020

Thomas Fleming

Thomas Fleming Receives 2020 Ward Cates Spirit Award

Oct 8, 2020

Join us

2020 HPTN Update Webinar

Sep 29, 2020

Adolescent boys

HPTN Launches HPTN 083-01

Jul 29, 2020

HPTN 083

HPTN 083 Study Demonstrates Superiority of Cabotegravir for the Prevention of HIV

Jul 7, 2020

Protests

HPTN Leadership's Response to Police Brutality

Jun 1, 2020

HPTN 083

CAB LA proves to be highly effective for prevention of HIV acquisition in cisgender men and transgender women

May 18, 2020